TY - JOUR
T1 - The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy
AU - Querin, Giorgia
AU - Lenglet, Timothée
AU - Debs, Rabab
AU - Stojkovic, Tanya
AU - Behin, Anthony
AU - Salachas, François
AU - Le Forestier, Nadine
AU - Amador, Maria del Mar
AU - Lacomblez, Lucette
AU - Meininger, Vincent
AU - Bruneteau, Gaelle
AU - Laforêt, Pascal
AU - Blancho, Sophie
AU - Marchand-Pauvert, Véronique
AU - Bede, Peter
AU - Hogrel, Jean Yves
AU - Pradat, Pierre François
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Objective: Objective of this study is the comprehensive characterisation of motor unit (MU) loss in type III and IV Spinal Muscular Atrophy (SMA) using motor unit number index (MUNIX), and evaluation of compensatory mechanisms based on MU size indices (MUSIX). Methods: Nineteen type III and IV SMA patients and 16 gender- and age-matched healthy controls were recruited. Neuromuscular performance was evaluated by muscle strength testing and functional scales. Compound motor action potential (CMAP), MUNIX and MUSIX were studied in the abductor pollicis brevis (APB), abductor digiti minimi (ADM), deltoid, tibialis anterior and trapezius muscles. A composite MUNIX score was also calculated. Results: SMA patients exhibited significantly reduced MUNIX values (p < 0.05) in all muscles, while MUSIX was increased, suggesting active re-innervation. Significant correlations were identified between MUNIX/MUSIX and muscle strength. Similarly, composite MUNIX scores correlated with disability scores. Interestingly, in SMA patients MUNIX was much lower in the ADM than in the ABP, a pattern which is distinctly different from that observed in Amyotrophic Lateral Sclerosis. Conclusions: MUNIX is a sensitive measure of MU loss in adult forms of SMA and correlates with disability. Significance: MUNIX evaluation is a promising candidate biomarker for longitudinal studies and pharmacological trials in adult SMA patients.
AB - Objective: Objective of this study is the comprehensive characterisation of motor unit (MU) loss in type III and IV Spinal Muscular Atrophy (SMA) using motor unit number index (MUNIX), and evaluation of compensatory mechanisms based on MU size indices (MUSIX). Methods: Nineteen type III and IV SMA patients and 16 gender- and age-matched healthy controls were recruited. Neuromuscular performance was evaluated by muscle strength testing and functional scales. Compound motor action potential (CMAP), MUNIX and MUSIX were studied in the abductor pollicis brevis (APB), abductor digiti minimi (ADM), deltoid, tibialis anterior and trapezius muscles. A composite MUNIX score was also calculated. Results: SMA patients exhibited significantly reduced MUNIX values (p < 0.05) in all muscles, while MUSIX was increased, suggesting active re-innervation. Significant correlations were identified between MUNIX/MUSIX and muscle strength. Similarly, composite MUNIX scores correlated with disability scores. Interestingly, in SMA patients MUNIX was much lower in the ADM than in the ABP, a pattern which is distinctly different from that observed in Amyotrophic Lateral Sclerosis. Conclusions: MUNIX is a sensitive measure of MU loss in adult forms of SMA and correlates with disability. Significance: MUNIX evaluation is a promising candidate biomarker for longitudinal studies and pharmacological trials in adult SMA patients.
KW - Biomarkers
KW - Motor unit loss
KW - MUNIX
KW - MUSIX
KW - SMA type III
KW - SMA type IV
UR - http://www.scopus.com/inward/record.url?scp=85053813318&partnerID=8YFLogxK
U2 - 10.1016/j.clinph.2018.08.025
DO - 10.1016/j.clinph.2018.08.025
M3 - Article
C2 - 30248623
AN - SCOPUS:85053813318
SN - 1388-2457
VL - 129
SP - 2333
EP - 2340
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
IS - 11
ER -